Genetic variations in the GR-encoding gene NR3C1 and mineralocorticoid receptor (MR)-encoding gene NR3C2 have been manifested in both bioinformatics and clinical studies to correlate with increased risks of cognitive impairments and HPA axis dysregulation [246, 249]. This evidence concerns the gene NR3C2 and Cognitive impairment.